About Scilex Holding Co. 
Scilex Holding Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 16 Schemes (6.49%)
Foreign Institutions
Held by 49 Foreign Institutions (2.05%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Mar 2026)
Net Profit:
-46 Million
Pharmaceuticals & Biotechnology
USD 439 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.37
178.20%
-2.48
Footer loading






